Monthly
US$200
Billed every month
Sign in to subscribeCelecoxib Capsules
As of 14 November 2026, for Celecoxib Capsules, 5 applications are listed as under review at China's CDE; 2 companies have filed new generic applications in 2026; the chemical-drug catalogue lists 27 holders.
Companies, stages and changes, with each record available on this page.
Listed in the US FDA Orange Book as CELEBREX (NDA 020998, UPJOHN US 2 LLC).
No changes recorded by this site in the last 90 days
Complete CDE snapshot: 2026/11/14 06:44
Current coverage may be incomplete
US Orange Book listing
The brand names come from the US FDA Orange Book and describe US listing records for this active ingredient. They do not indicate that products under these brand names are approved or sold in China, or that Chinese applicants are affiliated with US holders.
Orange Book source export date: 2026/11/06. Version: 2026-11-06.
Showing 3 of 3 distinct brand names.
A brand with different source forms or statuses can appear on multiple rows and in both groups. Distinct brand names are counted once globally, with a limit of five.
Verified official English dosage form: Capsules. Listings are grouped by the source dosage form and route; records without a clear correspondence are listed in the other group. Grouping does not establish product equivalence.
Same dosage form
| Brand name | Applicant (source text) | Application number | Dosage form (source text) | Route (source text) | Marketing status (source text) | Approval date |
|---|---|---|---|---|---|---|
| CELEBREX | UPJOHN US 2 LLC | NDA 020998 · Product no. 001, 002 | CAPSULE | ORAL | HUMAN PRESCRIPTION DRUG | 1998/12/31 |
| CELEBREX | UPJOHN US 2 LLC | NDA 020998 · Product no. 003 | CAPSULE | ORAL | HUMAN PRESCRIPTION DRUG | 2002/08/29 |
| CELEBREX | UPJOHN US 2 LLC | NDA 020998 · Product no. 004 | CAPSULE | ORAL | HUMAN PRESCRIPTION DRUG | 2006/12/15 |
Other dosage forms of the same ingredient
| Brand name | Applicant (source text) | Application number | Dosage form (source text) | Route (source text) | Marketing status (source text) | Approval date |
|---|---|---|---|---|---|---|
| ELYXYB | SCILEX PHARMACEUTICALS INC | NDA 212157 · Product no. 001 | SOLUTION | ORAL | HUMAN PRESCRIPTION DRUG | 2020/05/05 |
| VYSCOXA | CARWIN PHARMACEUTICAL ASSOCIATES LLC | NDA 211759 · Product no. 001 | SUSPENSION | ORAL | HUMAN PRESCRIPTION DRUG | 2025/07/29 |
Same-form/route listings come first, followed by other forms/routes. Within each group, source prescription/OTC listings precede discontinued listings; unknown statuses are last. Each status bucket is ordered by earliest approval date, ascending: pre-1982 records first, missing dates last; ties by brand name, application number and product number. The first five distinct brands in this order are selected globally. All retained source facts for those brands are shown in their own groups; a brand spanning both groups counts once.
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.
Catalogue holders27View records ↓
Under-review filings5View records ↓
This year’s generic filers2View records ↓
NHSA approval numbers36View records ↓
API companies with A status38View records ↓
Chemical-drug catalogue
Loaded records: 27 holders; 0 in the quality-and-efficacy consistency-evaluation category, and 25 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Jiangxi Shimei Pharmaceutical Co., Ltd | Jiangxi Shimei Pharmaceutical Co., Ltd | 国药准字H20256059 | 2025/11/25 | 0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Hui Zhi Pharmaceutical (Da Lian) Co., Ltd. romanized | Hui Zhi Pharmaceutical (Da Lian) Co., Ltd. romanized | 国药准字H20254652 | 2025/06/24 | 0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Yi Chang Ren Fu Pharma Co., Ltd. romanized | Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20249827 | 2024/12/25 | 0.2g | Not stated by source | CDE |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20244510 | 2024/07/30 | 0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Beijing Shi Qiao Biopharmaceutical Co., Ltd. romanized | Beijing Shi Qiao Biopharmaceutical Co., Ltd. romanized | 国药准字H20243917 | 2024/06/04 | 0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Hunan Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20243276 | 2024/02/23 | 0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Zhong Shan Ke Ke Kang Pharmaceutical Co., Ltd. romanized | Zhong Shan Ke Ke Kang Pharmaceutical Co., Ltd. romanized | 国药准字H20243287 | 2024/02/23 | 0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H20234697 | 2023/12/26 | 0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H20233911 | 2023/07/06 | 0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Yi Ling Wan Zhou International Pharmaceutical Co., Ltd. romanized | Yi Ling Wan Zhou International Pharmaceutical Co., Ltd. romanized | 国药准字H20233445 | 2023/04/11 | 0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Name not romanized | Name not romanized | 国药准字H20233449 | 2023/04/11 | 0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Yi Ling Wan Zhou International Pharmaceutical Co., Ltd. romanized | Yi Ling Wan Zhou International Pharmaceutical Co., Ltd. romanized | 国药准字H20233446 | 2023/04/11 | 0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H20223814 | 2022/11/08 | 0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Beijing Ya Bao Bio Pharma Co., Ltd. romanized | Beijing Ya Bao Bio Pharma Co., Ltd. romanized | 国药准字H20223018 | 2022/01/18 | 0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Beijing Ya Bao Bio Pharma Co., Ltd. romanized | Beijing Ya Bao Bio Pharma Co., Ltd. romanized | 国药准字H20223019 | 2022/01/18 | 0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Fujian Hai Xi Xin Yao Chuang Zhi Co., Ltd. romanized | Nanjing Bai Jing Yu Pharmaceutical Co., Ltd. romanized | 国药准字H20213779 | 2021/10/11 | 0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Bei Da Pharmaceuticals Co., Ltd. romanized | Bei Da Pharmaceuticals Co., Ltd. romanized | 国药准字H20213717 | 2021/09/13 | 0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Yang Zi Jiang Pharma Group Beijing Hai Yan Pharma Co., Ltd. romanized | Yang Zi Jiang Pharma Group Beijing Hai Yan Pharma Co., Ltd. romanized | 国药准字H20213586 | 2021/07/20 | 0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Sichuan Kelun Pharmaceutical Co., Ltd. | Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20213383 | 2021/05/19 | 0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Xian Sheng Pharma Co., Ltd. romanized | Xian Sheng Pharma Co., Ltd. romanized | 国药准字H20213058 | 2021/01/27 | 0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20213033 | 2021/01/19 | 0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Tianjin Jin Yao Pharma Co., Ltd. romanized | Tianjin Jin Yao Pharma Co., Ltd. romanized | 国药准字H20203706 | 2020/12/25 | 0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Tianjin Jin Yao Pharma Co., Ltd. romanized | Tianjin Jin Yao Pharma Co., Ltd. romanized | 国药准字H20203707 | 2020/12/25 | 0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Qilu Pharmaceutical (Hainan) Co., Ltd | Qilu Pharmaceutical (Hainan) Co., Ltd | 国药准字H20203490 | 2020/09/14 | 0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Qilu Pharmaceutical (Hainan) Co., Ltd | Qilu Pharmaceutical (Hainan) Co., Ltd | 国药准字H20203489 | 2020/09/14 | 0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Sichuan Gowell Pharmaceutical Co., Ltd. | Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H20203356 | 2020/07/29 | 0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Sichuan Gowell Pharmaceutical Co., Ltd. | Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H20203357 | 2020/07/29 | 0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Qingdao Bai Yang Pharmaceutical Co., Ltd. romanized | Qingdao Bai Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20203325 | 2020/07/21 | 0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Qingdao Bai Yang Pharmaceutical Co., Ltd. romanized | Qingdao Bai Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20203324 | 2020/07/21 | 0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20203297 | 2020/07/08 | 0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20203296 | 2020/07/08 | 0.1g | Generic approved under the new chemical-drug registration classification | CDE |
| Name not romanized | Jiangsu Zheng Da Qing Jiang Pharmaceutical Co., Ltd. romanized | 国药准字H20193414 | 2019/12/26 | 0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Heng Rui Pharmaceuticals Co., Ltd. romanized | Jiangsu Heng Rui Pharmaceuticals Co., Ltd. romanized | 国药准字H20193349 | 2019/11/28 | 0.2g | Generic approved under the new chemical-drug registration classification | CDE |
| G.D.Searle LLC | Pfizer Pharmaceuticals LLC | H20140107;H20140106 | 2000/08/04 | 0.2g | Imported originator drug | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 36 distinct approval numbers and 30 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| Beijing Shi Qiao Biopharmaceutical Co., Ltd. romanized | 国药准字H20243917 | 0.2g | Category B | XM01AHS002E001010100123 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20213033 | 0.2g | Category B | XM01AHS002E001010100177 | NHSA |
| Yang Zi Jiang Pharma Group Beijing Hai Yan Pharma Co., Ltd. romanized | 国药准字H20213586 | 0.2g | Category B | XM01AHS002E001010100237 | NHSA |
| Zhong Shan Ke Ke Kang Pharmaceutical Co., Ltd. romanized | 国药准字H20243287 | 0.2g | Category B | XM01AHS002E001010100361 | NHSA |
| Jin Yao He Ping (Tianjin) Pharmaceutical Co., Ltd. romanized | 国药准字H20203707 | 0.2g | Category B | XM01AHS002E001010100952 | NHSA |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20244510 | 0.2g | Category B | XM01AHS002E001010101397 | NHSA |
| Jiangsu Heng Rui Pharmaceuticals Co., Ltd. romanized | 国药准字H20193349 | 0.2g | Category B | XM01AHS002E001010101445 | NHSA |
| Jiangsu Zheng Da Qing Jiang Pharmaceutical Co., Ltd. romanized | 国药准字H20193414 | 0.2g | Category B | XM01AHS002E001010101522 | NHSA |
| Fujian Hai Xi Xin Yao Chuang Zhi Co., Ltd. romanized | 国药准字H20213779 | 0.2g | Category B | XM01AHS002E001010101554 | NHSA |
| Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20249827 | 0.2g | Category B | XM01AHS002E001010102000 | NHSA |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20213383 | 0.2g | Category B | XM01AHS002E001010102180 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20264321 | 0.2g | Category B | XM01AHS002E001010102251 | NHSA |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H20233911 | 0.2g | Category B | XM01AHS002E001010102273 | NHSA |
| Name not romanized | 国药准字H20233449 | 0.2g | Category B | XM01AHS002E001010102300 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20203296 | 0.1g | Category B | XM01AHS002E001010102770 | NHSA |
| Qingdao Bai Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20203324 | 0.1g | Category B | XM01AHS002E001010104023 | NHSA |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H20223814 | 0.2g | Category B | XM01AHS002E001010104744 | NHSA |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H20234697 | 0.2g | Category B | XM01AHS002E001010104833 | NHSA |
| Jiangxi Shimei Pharmaceutical Co., Ltd | 国药准字H20256059 | 0.2g | Category B | XM01AHS002E001010105356 | NHSA |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20203489 | 0.1g | Category B | XM01AHS002E001010105847 | NHSA |
| Xian Sheng Pharma Co., Ltd. romanized | 国药准字H20213058 | 0.2g | Category B | XM01AHS002E001010105849 | NHSA |
| Beijing Ya Bao Bio Pharma Co., Ltd. romanized | 国药准字H20223018 | 0.1g | Category B | XM01AHS002E001010109542 | NHSA |
| Bei Da Pharmaceuticals Co., Ltd. romanized | 国药准字H20213717 | 0.2g | Category B | XM01AHS002E001010109586 | NHSA |
| G.D.Searle LLC | 国药准字J20140072 | 0.2g | Category B | XM01AHS002E001010178724 | NHSA |
| Da Tong Pharmaceutical (Zhongguo) Co., Ltd. romanized | 国药准字H20255451 | 0.2g | Category B | XM01AHS002E001010180685 | NHSA |
| Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H20203356 | 0.1g | Category B | XM01AHS002E001010180937 | NHSA |
| Yi Ling Wan Zhou International Pharmaceutical Co., Ltd. romanized | 国药准字H20233445 | 0.1g | Category B | XM01AHS002E001010181048 | NHSA |
| Hunan Jiu Dian Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20243276 | 0.2g | Category B | XM01AHS002E001010184319 | NHSA |
| Hui Zhi Pharmaceutical (Da Lian) Co., Ltd. romanized | 国药准字H20254652 | 0.2g | Category B | XM01AHS002E001010185438 | NHSA |
| Beijing Shi Qiao Biopharmaceutical Co., Ltd. romanized | 国药准字H20243917 | 0.2g | Category B | XM01AHS002E001010200123 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20213033 | 0.2g | Category B | XM01AHS002E001010200177 | NHSA |
| Zhong Shan Ke Ke Kang Pharmaceutical Co., Ltd. romanized | 国药准字H20243287 | 0.2g | Category B | XM01AHS002E001010200361 | NHSA |
| Jin Yao He Ping (Tianjin) Pharmaceutical Co., Ltd. romanized | 国药准字H20203707 | 0.2g | Category B | XM01AHS002E001010200952 | NHSA |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20244510 | 0.2g | Category B | XM01AHS002E001010201397 | NHSA |
| Jiangsu Zheng Da Qing Jiang Pharmaceutical Co., Ltd. romanized | 国药准字H20193414 | 0.2g | Category B | XM01AHS002E001010201522 | NHSA |
| Fujian Hai Xi Xin Yao Chuang Zhi Co., Ltd. romanized | 国药准字H20213779 | 0.2g | Category B | XM01AHS002E001010201554 | NHSA |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20213383 | 0.2g | Category B | XM01AHS002E001010202180 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20264321 | 0.2g | Category B | XM01AHS002E001010202251 | NHSA |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H20233911 | 0.2g | Category B | XM01AHS002E001010202273 | NHSA |
| Name not romanized | 国药准字H20233449 | 0.2g | Category B | XM01AHS002E001010202300 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20203296 | 0.1g | Category B | XM01AHS002E001010202770 | NHSA |
| Qingdao Bai Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20203324 | 0.1g | Category B | XM01AHS002E001010204023 | NHSA |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H20223814 | 0.2g | Category B | XM01AHS002E001010204744 | NHSA |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H20234697 | 0.2g | Category B | XM01AHS002E001010204833 | NHSA |
| Jiangxi Shimei Pharmaceutical Co., Ltd | 国药准字H20256059 | 0.2g | Category B | XM01AHS002E001010205356 | NHSA |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20203489 | 0.1g | Category B | XM01AHS002E001010205847 | NHSA |
| Xian Sheng Pharma Co., Ltd. romanized | 国药准字H20213058 | 0.2g | Category B | XM01AHS002E001010205849 | NHSA |
| Bei Da Pharmaceuticals Co., Ltd. romanized | 国药准字H20213717 | 0.2g | Category B | XM01AHS002E001010209586 | NHSA |
| G.D.Searle LLC | 国药准字J20140072 | 0.2g | Category B | XM01AHS002E001010278724 | NHSA |
| Da Tong Pharmaceutical (Zhongguo) Co., Ltd. romanized | 国药准字H20255451 | 0.2g | Category B | XM01AHS002E001010280685 | NHSA |
| Yi Ling Wan Zhou International Pharmaceutical Co., Ltd. romanized | 国药准字H20233445 | 0.1g | Category B | XM01AHS002E001010281048 | NHSA |
| Hunan Jiu Dian Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20243276 | 0.2g | Category B | XM01AHS002E001010284319 | NHSA |
| Hui Zhi Pharmaceutical (Da Lian) Co., Ltd. romanized | 国药准字H20254652 | 0.2g | Category B | XM01AHS002E001010285438 | NHSA |
| Beijing Shi Qiao Biopharmaceutical Co., Ltd. romanized | 国药准字H20243917 | 0.2g | Category B | XM01AHS002E001010300123 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20213033 | 0.2g | Category B | XM01AHS002E001010300177 | NHSA |
| Zhong Shan Ke Ke Kang Pharmaceutical Co., Ltd. romanized | 国药准字H20243287 | 0.2g | Category B | XM01AHS002E001010300361 | NHSA |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20244510 | 0.2g | Category B | XM01AHS002E001010301397 | NHSA |
| Jiangsu Zheng Da Qing Jiang Pharmaceutical Co., Ltd. romanized | 国药准字H20193414 | 0.2g | Category B | XM01AHS002E001010301522 | NHSA |
| Fujian Hai Xi Xin Yao Chuang Zhi Co., Ltd. romanized | 国药准字H20213779 | 0.2g | Category B | XM01AHS002E001010301554 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20264321 | 0.2g | Category B | XM01AHS002E001010302251 | NHSA |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H20233911 | 0.2g | Category B | XM01AHS002E001010302273 | NHSA |
| Name not romanized | 国药准字H20233449 | 0.2g | Category B | XM01AHS002E001010302300 | NHSA |
| Qingdao Bai Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20203324 | 0.1g | Category B | XM01AHS002E001010304023 | NHSA |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H20223814 | 0.2g | Category B | XM01AHS002E001010304744 | NHSA |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H20234697 | 0.2g | Category B | XM01AHS002E001010304833 | NHSA |
| Xian Sheng Pharma Co., Ltd. romanized | 国药准字H20213058 | 0.2g | Category B | XM01AHS002E001010305849 | NHSA |
| Bei Da Pharmaceuticals Co., Ltd. romanized | 国药准字H20213717 | 0.2g | Category B | XM01AHS002E001010309586 | NHSA |
| G.D.Searle LLC | 国药准字J20140072 | 0.2g | Category B | XM01AHS002E001010378724 | NHSA |
| Da Tong Pharmaceutical (Zhongguo) Co., Ltd. romanized | 国药准字H20255451 | 0.2g | Category B | XM01AHS002E001010380685 | NHSA |
| Yi Ling Wan Zhou International Pharmaceutical Co., Ltd. romanized | 国药准字H20233445 | 0.1g | Category B | XM01AHS002E001010381048 | NHSA |
| Hunan Jiu Dian Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20243276 | 0.2g | Category B | XM01AHS002E001010384319 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20213033 | 0.2g | Category B | XM01AHS002E001010400177 | NHSA |
| Zhong Shan Ke Ke Kang Pharmaceutical Co., Ltd. romanized | 国药准字H20243287 | 0.2g | Category B | XM01AHS002E001010400361 | NHSA |
| Jiangsu Zheng Da Qing Jiang Pharmaceutical Co., Ltd. romanized | 国药准字H20193414 | 0.2g | Category B | XM01AHS002E001010401522 | NHSA |
| Fujian Hai Xi Xin Yao Chuang Zhi Co., Ltd. romanized | 国药准字H20213779 | 0.2g | Category B | XM01AHS002E001010401554 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20264321 | 0.2g | Category B | XM01AHS002E001010402251 | NHSA |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H20233911 | 0.2g | Category B | XM01AHS002E001010402273 | NHSA |
| Name not romanized | 国药准字H20233449 | 0.2g | Category B | XM01AHS002E001010402300 | NHSA |
| Qingdao Bai Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20203324 | 0.1g | Category B | XM01AHS002E001010404023 | NHSA |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H20223814 | 0.2g | Category B | XM01AHS002E001010404744 | NHSA |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H20234697 | 0.2g | Category B | XM01AHS002E001010404833 | NHSA |
| Bei Da Pharmaceuticals Co., Ltd. romanized | 国药准字H20213717 | 0.2g | Category B | XM01AHS002E001010409586 | NHSA |
| G.D.Searle LLC | 国药准字J20140072 | 0.2g | Category B | XM01AHS002E001010478724 | NHSA |
| Yi Ling Wan Zhou International Pharmaceutical Co., Ltd. romanized | 国药准字H20233445 | 0.1g | Category B | XM01AHS002E001010481048 | NHSA |
| Hunan Jiu Dian Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20243276 | 0.2g | Category B | XM01AHS002E001010484319 | NHSA |
| Zhong Shan Ke Ke Kang Pharmaceutical Co., Ltd. romanized | 国药准字H20243287 | 0.2g | Category B | XM01AHS002E001010500361 | NHSA |
| Jiangsu Zheng Da Qing Jiang Pharmaceutical Co., Ltd. romanized | 国药准字H20193414 | 0.2g | Category B | XM01AHS002E001010501522 | NHSA |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H20233911 | 0.2g | Category B | XM01AHS002E001010502273 | NHSA |
| Name not romanized | 国药准字H20233449 | 0.2g | Category B | XM01AHS002E001010502300 | NHSA |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H20223814 | 0.2g | Category B | XM01AHS002E001010504744 | NHSA |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H20234697 | 0.2g | Category B | XM01AHS002E001010504833 | NHSA |
| Bei Da Pharmaceuticals Co., Ltd. romanized | 国药准字H20213717 | 0.2g | Category B | XM01AHS002E001010509586 | NHSA |
| Hunan Jiu Dian Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20243276 | 0.2g | Category B | XM01AHS002E001010584319 | NHSA |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H20233911 | 0.2g | Category B | XM01AHS002E001010602273 | NHSA |
| Name not romanized | 国药准字H20233449 | 0.2g | Category B | XM01AHS002E001010602300 | NHSA |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H20223814 | 0.2g | Category B | XM01AHS002E001010604744 | NHSA |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H20234697 | 0.2g | Category B | XM01AHS002E001010604833 | NHSA |
| Upjohn US 2 LLC | 国药准字HJ20140106 | 0.2g | Category B | XM01AHS002E001010678724 | NHSA |
| Hunan Jiu Dian Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20243276 | 0.2g | Category B | XM01AHS002E001010684319 | NHSA |
| Zhong Shan Ke Ke Kang Pharmaceutical Co., Ltd. romanized | 国药准字H20243287 | 0.2g | Category B | XM01AHS002E001010700361 | NHSA |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H20233911 | 0.2g | Category B | XM01AHS002E001010702273 | NHSA |
| Name not romanized | 国药准字H20233449 | 0.2g | Category B | XM01AHS002E001010702300 | NHSA |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H20223814 | 0.2g | Category B | XM01AHS002E001010704744 | NHSA |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H20234697 | 0.2g | Category B | XM01AHS002E001010704833 | NHSA |
| Upjohn US 2 LLC | 国药准字HJ20140106 | 0.2g | Category B | XM01AHS002E001010778724 | NHSA |
| Hunan Jiu Dian Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20243276 | 0.2g | Category B | XM01AHS002E001010784319 | NHSA |
| Zhong Shan Ke Ke Kang Pharmaceutical Co., Ltd. romanized | 国药准字H20243287 | 0.2g | Category B | XM01AHS002E001010800361 | NHSA |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H20233911 | 0.2g | Category B | XM01AHS002E001010802273 | NHSA |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H20223814 | 0.2g | Category B | XM01AHS002E001010804744 | NHSA |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H20234697 | 0.2g | Category B | XM01AHS002E001010804833 | NHSA |
| Upjohn US 2 LLC | 国药准字HJ20140106 | 0.2g | Category B | XM01AHS002E001010878724 | NHSA |
| Hunan Jiu Dian Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20243276 | 0.2g | Category B | XM01AHS002E001010884319 | NHSA |
| Zhong Shan Ke Ke Kang Pharmaceutical Co., Ltd. romanized | 国药准字H20243287 | 0.2g | Category B | XM01AHS002E001010900361 | NHSA |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H20233911 | 0.2g | Category B | XM01AHS002E001010902273 | NHSA |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H20223814 | 0.2g | Category B | XM01AHS002E001010904744 | NHSA |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H20234697 | 0.2g | Category B | XM01AHS002E001010904833 | NHSA |
| Upjohn US 2 LLC | 国药准字HJ20140106 | 0.2g | Category B | XM01AHS002E001010978724 | NHSA |
| Hunan Jiu Dian Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20243276 | 0.2g | Category B | XM01AHS002E001010984319 | NHSA |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H20233911 | 0.2g | Category B | XM01AHS002E001011002273 | NHSA |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H20223814 | 0.2g | Category B | XM01AHS002E001011004744 | NHSA |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H20234697 | 0.2g | Category B | XM01AHS002E001011004833 | NHSA |
| Hunan Jiu Dian Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20243276 | 0.2g | Category B | XM01AHS002E001011084319 | NHSA |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H20233911 | 0.2g | Category B | XM01AHS002E001011102273 | NHSA |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H20223814 | 0.2g | Category B | XM01AHS002E001011104744 | NHSA |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H20234697 | 0.2g | Category B | XM01AHS002E001011104833 | NHSA |
| Hunan Jiu Dian Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20243276 | 0.2g | Category B | XM01AHS002E001011184319 | NHSA |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H20233911 | 0.2g | Category B | XM01AHS002E001011202273 | NHSA |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H20223814 | 0.2g | Category B | XM01AHS002E001011204744 | NHSA |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H20234697 | 0.2g | Category B | XM01AHS002E001011204833 | NHSA |
| Hunan Jiu Dian Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20243276 | 0.2g | Category B | XM01AHS002E001011284319 | NHSA |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H20233911 | 0.2g | Category B | XM01AHS002E001011302273 | NHSA |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H20223814 | 0.2g | Category B | XM01AHS002E001011304744 | NHSA |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H20234697 | 0.2g | Category B | XM01AHS002E001011304833 | NHSA |
| Hunan Jiu Dian Nuo Na Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20243276 | 0.2g | Category B | XM01AHS002E001011384319 | NHSA |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H20233911 | 0.2g | Category B | XM01AHS002E001011402273 | NHSA |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | 国药准字H20223814 | 0.2g | Category B | XM01AHS002E001011404744 | NHSA |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H20234697 | 0.2g | Category B | XM01AHS002E001011404833 | NHSA |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H20233911 | 0.2g | Category B | XM01AHS002E001011502273 | NHSA |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H20234697 | 0.2g | Category B | XM01AHS002E001011504833 | NHSA |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H20233911 | 0.2g | Category B | XM01AHS002E001011602273 | NHSA |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H20234697 | 0.2g | Category B | XM01AHS002E001011604833 | NHSA |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H20233911 | 0.2g | Category B | XM01AHS002E001011702273 | NHSA |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H20234697 | 0.2g | Category B | XM01AHS002E001011704833 | NHSA |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H20233911 | 0.2g | Category B | XM01AHS002E001011802273 | NHSA |
| Fuzhou Min Hai Pharma Co., Ltd. romanized | 国药准字H20234697 | 0.2g | Category B | XM01AHS002E001011804833 | NHSA |
| Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanized | 国药准字H20233911 | 0.2g | Category B | XM01AHS002E001011902273 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20203297 | 0.2g | Category B | XM01AHS002E001020102770 | NHSA |
| Qingdao Bai Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20203325 | 0.2g | Category B | XM01AHS002E001020104023 | NHSA |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20203490 | 0.2g | Category B | XM01AHS002E001020105847 | NHSA |
| Xian Sheng Pharma Co., Ltd. romanized | 国药准字H20213058 | 0.2g | Category B | XM01AHS002E001020105849 | NHSA |
| Beijing Ya Bao Bio Pharma Co., Ltd. romanized | 国药准字H20223019 | 0.2g | Category B | XM01AHS002E001020109542 | NHSA |
| Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H20203357 | 0.2g | Category B | XM01AHS002E001020180937 | NHSA |
| Yi Ling Wan Zhou International Pharmaceutical Co., Ltd. romanized | 国药准字H20233446 | 0.2g | Category B | XM01AHS002E001020181048 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20203297 | 0.2g | Category B | XM01AHS002E001020202770 | NHSA |
| Qingdao Bai Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20203325 | 0.2g | Category B | XM01AHS002E001020204023 | NHSA |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20203490 | 0.2g | Category B | XM01AHS002E001020205847 | NHSA |
| Beijing Ya Bao Bio Pharma Co., Ltd. romanized | 国药准字H20223019 | 0.2g | Category B | XM01AHS002E001020209542 | NHSA |
| Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H20203357 | 0.2g | Category B | XM01AHS002E001020280937 | NHSA |
| Yi Ling Wan Zhou International Pharmaceutical Co., Ltd. romanized | 国药准字H20233446 | 0.2g | Category B | XM01AHS002E001020281048 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20203297 | 0.2g | Category B | XM01AHS002E001020302770 | NHSA |
| Qingdao Bai Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20203325 | 0.2g | Category B | XM01AHS002E001020304023 | NHSA |
| Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H20203357 | 0.2g | Category B | XM01AHS002E001020380937 | NHSA |
| Yi Ling Wan Zhou International Pharmaceutical Co., Ltd. romanized | 国药准字H20233446 | 0.2g | Category B | XM01AHS002E001020381048 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20203297 | 0.2g | Category B | XM01AHS002E001020402770 | NHSA |
| Qingdao Bai Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20203325 | 0.2g | Category B | XM01AHS002E001020404023 | NHSA |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20203490 | 0.2g | Category B | XM01AHS002E001020405847 | NHSA |
| Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H20203357 | 0.2g | Category B | XM01AHS002E001020480937 | NHSA |
| Yi Ling Wan Zhou International Pharmaceutical Co., Ltd. romanized | 国药准字H20233446 | 0.2g | Category B | XM01AHS002E001020481048 | NHSA |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20203490 | 0.2g | Category B | XM01AHS002E001020505847 | NHSA |
| Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H20203357 | 0.2g | Category B | XM01AHS002E001020580937 | NHSA |
| Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H20203357 | 0.2g | Category B | XM01AHS002E001020680937 | NHSA |
| Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H20203357 | 0.2g | Category B | XM01AHS002E001020780937 | NHSA |
| Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H20203357 | 0.2g | Category B | XM01AHS002E001020880937 | NHSA |
| Sichuan Gowell Pharmaceutical Co., Ltd. | 国药准字H20203357 | 0.2g | Category B | XM01AHS002E001020980937 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20264321 | 0.2g | Category B | XM01AHS002E001010502251 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20264321 | 0.2g | Category B | XM01AHS002E001010602251 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 5 filings and 4 distinct first applicants.
Generic 4 · Supplement 1
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Di Sha Pharma Group Co., Ltd. romanized | CYHS2600766 | Generic | 2026/04/02 | Not stated by source | CDE |
| Shaanxi Xi Yue Pharmaceutical Co., Ltd. romanized | CYHS2601941 | Generic | 2026/08/10 | Not stated by source | CDE |
| Sichuan Gowell Pharmaceutical Co., Ltd. | CYHB2601446 | Supplement | 2026/07/28 | Not stated by source | CDE |
| Jilin Ya Tai Yong An Tang Pharma Co., Ltd. romanized | CYHS2502959 | Generic | 2025/08/13 | Not stated by source | CDE |
| Jilin Ya Tai Yong An Tang Pharma Co., Ltd. romanized | CYHS2502958 | Generic | 2025/08/13 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 2 filings and 2 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Di Sha Pharma Group Co., Ltd. romanized | CYHS2600766 | Generic | 2026/04/02 | Not stated by source | CDE |
| Shaanxi Xi Yue Pharmaceutical Co., Ltd. romanized | CYHS2601941 | Generic | 2026/08/10 | Not stated by source | CDE |
API registrations
Non-component matches: 38 companies with A status and 14 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 塞来昔布 · No verified English name | Shaanxi Xi Yue Pharmaceutical (Fu Feng) Co., Ltd. romanized | Y20260000229 | I | Exact ingredient | 2026/04/09 | CDE |
| 塞来昔布 · No verified English name | Shanghai Jin Di Jiu Zhou Pharma (An Yang) Co., Ltd. romanized | Y20240001315 | A | Exact ingredient | 2026/06/17 | CDE |
| 塞来昔布 · No verified English name | Jiangxi Tong He Pharma Co., Ltd. romanized | Y20240001113 | A | Exact ingredient | 2026/05/28 | CDE |
| 塞来昔布 · No verified English name | Shandong Lukang Pharmaceutical Co.,Ltd. | Y20230001246 | A | Exact ingredient | 2025/04/30 | CDE |
| 塞来昔布 · No verified English name | Anhui Yue Kang Kai Yue Pharmaceutical Co., Ltd. romanized | Y20230000906 | A | Exact ingredient | 2025/07/04 | CDE |
| 塞来昔布 · No verified English name | Qian Hui Pharma (Anhui) Co., Ltd. romanized | Y20230000649 | A | Exact ingredient | 2024/12/30 | CDE |
| 塞来昔布 · No verified English name | Kunming Yuan Rui Pharmaceutical Co., Ltd. romanized | Y20230000320 | A | Exact ingredient | 2024/09/25 | CDE |
| 塞来昔布 · No verified English name | Shandong Dao He Pharma Co., Ltd. romanized | Y20230000076 | A | Exact ingredient | 2024/06/28 | CDE |
| 塞来昔布 · No verified English name | Hubei Sheng Hong Yuan Pharma Technology Co., Ltd. romanized | Y20210000794 | A | Exact ingredient | 2024/02/08 | CDE |
| 塞来昔布 · No verified English name | Hunan Jiu Dian Hong Yang Pharmaceutical Co., Ltd. romanized | Y20210000947 | A | Exact ingredient | 2024/02/02 | CDE |
| 塞来昔布 · No verified English name | Upjohn US 2 LLC | Y20200001454 | A | Exact ingredient | 2026/04/11 | CDE |
| 塞来昔布 · No verified English name | Nan Tong Chang You Pharma Technology Co., Ltd. romanized | Y20210000043 | A | Exact ingredient | 2023/09/27 | CDE |
| 塞来昔布 · No verified English name | Aurore Pharmaceuticals Private Limited | Y20200001196 | I | Exact ingredient | 2022/11/11 | CDE |
| 塞来昔布 · No verified English name | Henan Dong Tai Pharmaceutical Co., Ltd. romanized | Y20200000335 | A | Exact ingredient | 2025/08/09 | CDE |
| 塞来昔布 · No verified English name | Name not romanized | Y20190000593 | I | Exact ingredient | 2023/08/11 | CDE |
| 塞来昔布 · No verified English name | Kekule Pharma Limited | Y20190001045 | I | Exact ingredient | 2020/03/24 | CDE |
| 塞来昔布 · No verified English name | CIPLA LTD. | Y20190021376 | I | Exact ingredient | 2020/01/10 | CDE |
| 塞来昔布 · No verified English name | Sichuan Kelun Pharmaceutical Co., Ltd. | Y20190021398 | A | Exact ingredient | 2026/03/21 | CDE |
| 塞来昔布 · No verified English name | Yang Zi Jiang Pharma Group Jiangsu Hai Ci Bio Pharma Co., Ltd. romanized | Y20190021195 | A | Exact ingredient | 2026/05/22 | CDE |
| 塞来昔布 · No verified English name | Jiangsu Zheng Da Qing Jiang Pharmaceutical Co., Ltd. romanized | Y20190009882 | A | Exact ingredient | — | CDE |
| 塞来昔布 · No verified English name | Upjohn US 2 LLC | Y20190009148 | A | Exact ingredient | 2024/10/29 | CDE |
| 塞来昔布 · No verified English name | Jiangsu Heng Rui Pharmaceuticals Co., Ltd. romanized | Y20190007241 | A | Exact ingredient | 2023/06/07 | CDE |
| 塞来昔布 · No verified English name | Sichuan Gowell Pharmaceutical Co., Ltd. | Y20180001644 | A | Exact ingredient | 2025/05/07 | CDE |
| 塞来昔布 · No verified English name | Tian Di Heng Yi Pharmaceutical Co., Ltd. romanized | Y20180001654 | I | Exact ingredient | 2019/03/13 | CDE |
| 塞来昔布 · No verified English name | Jiangsu Run An Pharmaceutical Co., Ltd. romanized | Y20180001195 | A | Exact ingredient | 2024/12/27 | CDE |
| 塞来昔布 · No verified English name | Shandong Lang Nuo Pharmaceutical Co., Ltd. romanized | Y20180000610 | A | Exact ingredient | 2023/07/31 | CDE |
| 塞来昔布 · No verified English name | Rui Yang Pharmaceutical Co., Ltd. romanized | Y20170002232 | A | Exact ingredient | 2026/02/14 | CDE |
| 塞来昔布 · No verified English name | Jiangxi Tong He Pharma Co., Ltd. romanized | Y20180000172 | A | Exact ingredient | 2025/07/04 | CDE |
| 塞来昔布 · No verified English name | Qingdao Guo Hai Biopharmaceutical Co., Ltd. romanized | Y20170001448 | I | Exact ingredient | — | CDE |
| 塞来昔布 · No verified English name | Yan Tai Wan Run Pharma Co., Ltd. romanized | Y20170001331 | I | Exact ingredient | — | CDE |
| 塞来昔布 · No verified English name | Hunan Fang Sheng Pharmaceutical Co., Ltd. romanized | Y20170001323 | A | Exact ingredient | 2024/07/02 | CDE |
| 塞来昔布 · No verified English name | Fujian Sheng Fu Kang Pharma Co., Ltd. romanized | Y20170001322 | A | Exact ingredient | 2025/07/28 | CDE |
| 塞来昔布 · No verified English name | Di Jia Pharma Group Co., Ltd. romanized | Y20170001274 | A | Exact ingredient | 2026/09/01 | CDE |
| 塞来昔布 · No verified English name | Suzhou Zheng Ji Pharma Co., Ltd. romanized | Y20170001197 | I | Exact ingredient | — | CDE |
| 塞来昔布 · No verified English name | Hebei Ren He Yi Kang Pharma Co., Ltd. romanized | Y20170001130 | I | Exact ingredient | — | CDE |
| 塞来昔布 · No verified English name | Ai Mei Ke Jian (Zhongguo) Biopharmaceuticals Co., Ltd. romanized | Y20170001107 | I | Exact ingredient | 2025/01/04 | CDE |
| 塞来昔布 · No verified English name | Hubei Mei Lin Pharma Co., Ltd. romanized | Y20170001098 | A | Exact ingredient | 2025/04/23 | CDE |
| 塞来昔布 · No verified English name | Ai Mei Ke Jian (Zhongguo) Biopharmaceuticals Co., Ltd. romanized | Y20170001077 | A | Exact ingredient | 2024/01/16 | CDE |
| 塞来昔布 · No verified English name | AARTI DRUGS LIMITED | Y20170001023 | I | Exact ingredient | — | CDE |
| 塞来昔布 · No verified English name | Apitoria Pharma Private Limited | Y20170001012 | A | Exact ingredient | 2025/09/15 | CDE |
| 塞来昔布 · No verified English name | Shenzhen Shi Hai Bin Pharmaceutical Co., Ltd. romanized | Y20170000973 | A | Exact ingredient | 2024/06/06 | CDE |
| 塞来昔布 · No verified English name | Ji Ning Shen Zhou Pharmaceuticals Co., Ltd. romanized | Y20170000869 | A | Exact ingredient | 2026/04/01 | CDE |
| 塞来昔布 · No verified English name | Shandong Cheng Hui Shuang Da Pharma Co., Ltd. romanized | Y20170000787 | A | Exact ingredient | 2026/07/24 | CDE |
| 塞来昔布 · No verified English name | Nanjing Yi Hua Pharma Co., Ltd. romanized | Y20170000783 | A | Exact ingredient | 2024/10/01 | CDE |
| 塞来昔布 · No verified English name | Jin Yao Pharma Co., Ltd. romanized | Y20170000774 | A | Exact ingredient | 2024/11/26 | CDE |
| 塞来昔布 · No verified English name | Shandong An Xin Pharmaceutical Co., Ltd. romanized | Y20170000772 | A | Exact ingredient | 2026/10/29 | CDE |
| 塞来昔布 · No verified English name | Macleods Pharmaceuticals Limited | Y20170000770 | A | Exact ingredient | 2024/01/17 | CDE |
| 塞来昔布 · No verified English name | Hubei Hua Shi Tong Biopharmaceuticals Technology Co., Ltd. romanized | Y20170000767 | A | Exact ingredient | 2024/02/08 | CDE |
| 塞来昔布 · No verified English name | Tianjin Shi Zhong Yang Pharma Co., Ltd. romanized | Y20170000723 | A | Exact ingredient | 2025/06/05 | CDE |
| 塞来昔布 · No verified English name | Alembic Pharmaceuticals Limited | Y20170000568 | A | Exact ingredient | 2025/02/07 | CDE |
| 塞来昔布 · No verified English name | Chi Zhou Dong Sheng Pharma Co., Ltd. romanized | Y20170000496 | I | Exact ingredient | — | CDE |
| 塞来昔布 · No verified English name | Hetero Drugs Limited, Unit-IX | Y20170000465 | A | Exact ingredient | 2024/11/26 | CDE |
| 塞来昔布 · No verified English name | Zhejiang Hai Zheng Pharma Co., Ltd. romanized | Y20170000353 | A | Exact ingredient | 2024/09/12 | CDE |
| 塞来昔布 · No verified English name | Cadila Pharmaceuticals Limited | Y20170000300 | I | Exact ingredient | — | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/14 06:40. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
- No matching records were found in the currently loaded source data; coverage dates are listed below.
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/14 06:44
- Chemical-drug catalogue
- Last successful update: 2026/11/14 06:40
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/14 06:43
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/14 18:32
First index-page publication dates: 2026-10-29 to 2026-11-13; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/14 08:10 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 7/30; discovered pending details: 0. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Celecoxib Capsules
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Sign in to subscribeYearly
US$1,920
Billed every year
US$160 per month
Sign in to subscribeNeed more than 10 followed products or more than 5 recipients? Contact us.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy